MedPath

Transition to Adulthood Through Coaching and Empowerment in Rheumatology

Not Applicable
Recruiting
Conditions
Juvenile Rheumatoid Arthritis
Autoimmune Diseases
Juvenile Dermatomyositis
Juvenile Psoriatic Arthritis
Autoinflammatory Disease
Juvenile Idiopathic Arthritis
Lupus Erythematosus
Interventions
Behavioral: Transition coaching
Registration Number
NCT05545839
Lead Sponsor
McMaster University
Brief Summary

TRACER is a study aiming to investigate the feasibility of transition coaching sessions for patients moving from paediatric to adult rheumatology care.

Detailed Description

TRACER is a feasibility study investigating transition coaching for patients with rheumatic disease transferring from paediatric to adult rheumatology care. This is a vulnerable time in the patients' care and life as they are assuming more responsibility for their health and undergoing significant life transitions. There is risk for increased morbidity and mortality around this time if the patient are not well supported and if they do not stay engaged with care. This intervention aim to provide self-efficacy, self-management, coping skills and support to patients making the transition. This study aims to assess the feasibility of conducting a multi-centre randomized trial.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
133
Inclusion Criteria
  • Patient with pediatic-onset rheumatic disease
  • At their last paediatric rheumatology appointment prior to transferring to adult rheumatology care
  • Able to communicate in English
  • Have a phone or device capable of participating in video conference
  • Available over the next 8 months
Exclusion Criteria
  • Cognitive impairment preventing participation in individualized education sessions (as determined by medical staff)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Transition coaching - experimentalTransition coachingParticipants will receive 8 transition coaching sessions (1/month) in addition to standard care
Primary Outcome Measures
NameTimeMethod
Missing data3 year study period

% of missing data

Consent rate19 month recruitment period

% of patients approached who consent to the study

Virtual session attendance3 year study period

% of transition coaching sessions attended

Outcome measure completion3 year study period

% of outcome assessments completed at 8 months (end of transition coach invention)

Enrolment from non-primary site19 month

% of patients enrolled from non-primary site

Secondary Outcome Measures
NameTimeMethod
Global function/quality of life3 year study period

Descriptive statistics of PedsQL (Paediatric Quality of Life Inventory) 4.0 Generic Core Scales Young Adult Version questionnaire results at baseline, 8 months and 11 months, between the two groups.

Patient Reported Outcomes Measurement Information System (PROMIS) questionnaire3 year study period

Descriptive statistics of PROMIS questionnaire (person-centered measures to assess how people feel and function) results at baseline, 8 months and 11 months, between the two groups.

Physician Global Assessment (PGA)3 year study period

Descriptive statistics of physical global assessment at baseline and at subsequent follow-up, between the two groups. Physician Global Assessment refers to MD assessment of disease activity and is rated between 0 (no disease activity) and 10 (most active disease).

Active joint count3 year study period

Descriptive statistics of active joint count (joints with evidence of active inflammation - including swelling, tenderness, loss of ROM) at baseline and at subsequent follow-up, between the two groups

Trial Locations

Locations (2)

McMaster Children's Hospital

🇨🇦

Hamilton, Ontario, Canada

Children's Hospital at London Health Sciences Centre

🇨🇦

London, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath